BIOCON
Quarterly Results Analysis [Mar2024]
BIOCON Quarterly Results
Consolidated | Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,917 Cr | ₹3,954 Cr | ₹3,462 Cr | ₹3,423 Cr | ₹3,774 Cr | ₹2,941 Cr | ₹2,320 Cr | ₹2,140 Cr |
Expenses | ₹3,001 Cr | ₹3,027 Cr | ₹2,721 Cr | ₹2,708 Cr | ₹2,777 Cr | ₹2,297 Cr | ₹1,849 Cr | ₹1,740 Cr |
Operating Income | ₹916 Cr | ₹927 Cr | ₹742 Cr | ₹714 Cr | ₹997 Cr | ₹644 Cr | ₹471 Cr | ₹399 Cr |
Other Income | ₹49 Cr | ₹566 Cr | ₹158 Cr | ₹94 Cr | ₹155 Cr | ₹79 Cr | ₹65 Cr | ₹78 Cr |
Interest | ₹227 Cr | ₹267 Cr | ₹248 Cr | ₹233 Cr | ₹249 Cr | ₹120 Cr | ₹30 Cr | ₹20 Cr |
Depreciation | ₹407 Cr | ₹415 Cr | ₹389 Cr | ₹358 Cr | ₹364 Cr | ₹301 Cr | ₹231 Cr | ₹218 Cr |
Profit Before Tax | ₹322 Cr | ₹832 Cr | ₹239 Cr | ₹217 Cr | ₹537 Cr | ₹30 Cr | ₹257 Cr | ₹240 Cr |
Profit After Tax | ₹226 Cr | ₹777 Cr | ₹197 Cr | ₹182 Cr | ₹455 Cr | ₹35 Cr | ₹110 Cr | ₹210 Cr |
EPS | ₹1.13 | ₹5.50 | ₹1.05 | ₹0.84 | ₹2.61 | ₹-0.35 | ₹0.39 | ₹1.20 |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOCON | 4.8% | 10.3% | 31.3% |
SUN PHARMACEUTICAL INDUSTRIES | -2.9% | 0% | 59.6% |
CIPLA | 5.8% | 6.2% | 60.9% |
DR REDDYS LABORATORIES | 0.9% | -1.5% | 32.2% |
ZYDUS LIFESCIENCES | -2.6% | 15.3% | 114.4% |
DIVIS LABORATORIES | 5% | 8% | 25.9% |
MANKIND PHARMA | -2.3% | -14% | 57.7% |
TORRENT PHARMACEUTICALS | -3.4% | -2.7% | 61.2% |
LUPIN | -2.8% | 2.1% | 110.5% |
BIOCON Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -0.93 % |
Y-o-Y | 3.79 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹3,917 Cr | -0.93 | |
Dec2023 | ₹3,954 Cr | 14.19 | |
Sep2023 | ₹3,462 Cr | 1.16 | |
Jun2023 | ₹3,423 Cr | -9.31 | |
Mar2023 | ₹3,774 Cr | 28.32 | |
Dec2022 | ₹2,941 Cr | 26.79 | |
Sep2022 | ₹2,320 Cr | 8.42 | |
Jun2022 | ₹2,140 Cr | - |
BIOCON Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -1.18 % |
Y-o-Y | -8.16 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹916 Cr | -1.18 | |
Dec2023 | ₹927 Cr | 24.97 | |
Sep2023 | ₹742 Cr | 3.81 | |
Jun2023 | ₹714 Cr | -28.37 | |
Mar2023 | ₹997 Cr | 54.79 | |
Dec2022 | ₹644 Cr | 36.88 | |
Sep2022 | ₹471 Cr | 17.85 | |
Jun2022 | ₹399 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.26 % |
Y-o-Y | -11.54 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 23.38% | -0.26 | |
Dec2023 | 23.44% | 9.43 | |
Sep2023 | 21.42% | 2.64 | |
Jun2023 | 20.87% | -21.04 | |
Mar2023 | 26.43% | 20.63 | |
Dec2022 | 21.91% | 7.98 | |
Sep2022 | 20.29% | 8.68 | |
Jun2022 | 18.67% | - |
BIOCON Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -70.98 % |
Y-o-Y | -50.37 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹226 Cr | -70.98 | |
Dec2023 | ₹777 Cr | 294.82 | |
Sep2023 | ₹197 Cr | 8.13 | |
Jun2023 | ₹182 Cr | -59.94 | |
Mar2023 | ₹455 Cr | 1,202.58 | |
Dec2022 | ₹35 Cr | -68.30 | |
Sep2022 | ₹110 Cr | -47.67 | |
Jun2022 | ₹210 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -70.70 % |
Y-o-Y | -52.20 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 5.76 % | -70.70 | |
Dec2023 | 19.66 % | 245.52 | |
Sep2023 | 5.69 % | 6.95 | |
Jun2023 | 5.32 % | -55.85 | |
Mar2023 | 12.05 % | 912.61 | |
Dec2022 | 1.19 % | -74.95 | |
Sep2022 | 4.75 % | -51.68 | |
Jun2022 | 9.83 % | - |
BIOCON Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -79.45 % |
Y-o-Y | -56.70 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹1.13 | -79.45 | |
Dec2023 | ₹5.5 | 423.81 | |
Sep2023 | ₹1.05 | 25.00 | |
Jun2023 | ₹0.84 | -67.82 | |
Mar2023 | ₹2.61 | Positive | |
Dec2022 | ₹-0.35 | Negative | |
Sep2022 | ₹0.39 | -67.50 | |
Jun2022 | ₹1.2 | - |
You may also like the below Video Courses